Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06386588 · ClinicalTrials.gov registry record · NA

The Effects of Auditory Stimulation During Sleep on Brain Networks in Schizophrenia

A NA study of Schizophrenia, sponsored by Massachusetts General Hospital.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT06386588: Recruiting NA study of Schizophrenia, sponsored by Massachusetts General Hospital.

NCT06386588 is a NA study of Schizophrenia that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 60 participants, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06386588, a NA study of Schizophrenia, is actively recruiting participants, sponsored by Massachusetts General Hospital.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

In this research study the investigators will use sleep headbands to measure brain rhythms and to improve their coordination across brain regions. The headbands will be worn at home for multiple nights. On some nights the headbands will play soft sounds at specific times during sleep. The investigators are interested in learning whether this timed auditory stimulation may be a strategy to improve the coordination of sleep rhythms across brain regions, improve network communication, and as a result, improve memory. The investigators will study 30 adults aged 18-45 with schizophrenia and 30 demographically matched healthy controls. Participants will first have a daytime MRI scan, during which they will complete a finger tapping motor sequence task (MST), followed by a week of sleep at home with a sleep headband. They will also do the MST at home on two of the nights. On the final day of the study, participants will return for a second MRI scan.

Primary Outcome

Changes in slow oscillations, sleep spindles, and slow oscillation-spindle coupled events as measured by sleep EEG headband

Conditions Studied

Interventions

  • OTHER Closed loop auditory stimulation during sleep

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Charlestown

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2025-02-05
Est. Completion 2027-12-31
Phase NA
Massachusetts General Hospital

2,032 total trials

What NCT06386588 shows while recruiting

NCT06386588 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (73% lower).

The record links to 1 condition, with Schizophrenia appearing as the primary indexed condition, and to 1 intervention - of which Closed loop auditory stimulation during sleep is the first listed.

NCT06386588 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06386588 about?

NCT06386588 is a clinical study titled "The Effects of Auditory Stimulation During Sleep on Brain Networks in Schizophrenia". In this research study the investigators will use sleep headbands to measure brain rhythms and to improve their coordination across brain regions. The headbands will be worn at home for multiple nights. On some nights the headbands will play soft sounds at specific times during sleep. The investigat...

What is the current status of trial NCT06386588?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-02-05. Estimated completion is 2027-12-31.

What conditions does trial NCT06386588 study?

This clinical trial studies the following conditions: Schizophrenia.

What interventions are being tested in trial NCT06386588?

The interventions under investigation include: Closed loop auditory stimulation during sleep (OTHER).

Who is sponsoring clinical trial NCT06386588?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06386588 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Schizophrenia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06386588's enrollment target sits among peer trials

60 188th of 315 higher than 119 of 315 other Schizophrenia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Schizophrenia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06386588, the US trial registry maintained by the National Library of Medicine. NCT06386588 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.